Digital Pathology Market Report- Expansive Coverage on the Profit Sources

InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"

The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91% during the forecast period.

Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1629

The ageing population and the increasing prevalence of chronic diseases present opportunities for remote patient monitoring solutions. The COVID-19 pandemic has significantly influenced the widespread adoption of telehealth services. In 2023, North America held most of the market and contributed a portion of the global revenue. Traditional healthcare systems may be hesitant to adopt digital the growing prevalence of cancer, the expanding use of digital pathology in pharmaceutical research and online as part, and the increasing acceptance of digital pathology to improve lab efficiency are the primary drivers of the market's growth. The essential source for developing advanced diagnostic solutions is the rising prevalence of cardiovascular disorders.

Thus, the need for digital pathology systems increases and is driving the growth of the digital pathology market during the forecast period. Moreover, advancements in technologies such as computerization, robotic light microscopy, and multiple fiber optic communications are important key factors projected to increase the adoption of digital pathology in the years to come. The introduction of affordable scanners and the propensity of small players to move towards digitization of pathology workflow is fueling the market's growth over the upcoming years. Additionally, the launch of cloud-based technology allows the storage of digital slides associated with protected access to pathologists, which is predicted to contribute to the potential growth of the digital pathology market in the coming years. However, the high cost of these systems, coupled with the challenge of a shortage of skilled personnel to operate digital pathology systems, is expected to limit the adoption of these systems. health technologies because of concerns regarding disruption, changes in workflow, and the necessity of additional training.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1629

List of Prominent Players in the Digital Pathology Market:
• Akoya Biosciences (US)
• Corista (US)
• Indica Labs (US)
• Objective Pathology Services (Canada)
• Sectra AB (Sweden)
• OptraSCAN (US)
• Biosystems (US)
• Koninklijke Philips N.V. (Netherlands)
• Hamamatsu Photonics (Japan)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• 3DHISTECH (Hungary)
• Apollo Enterprise Imaging (US)
• XIFIN, Inc. (US)
• Huron Digital Pathology (Canada)
• Visiopharm A/S (Denmark)
• Aiforia Technologies Oy (Finland)
• Glencoe Software (US)
• KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
• Inspirata, Inc. (US)
• PathAI (US)
• Proscia Inc. (US)
• Kanteron Systems (Spain)
• Mikroscan Technologies (US)
• Motic (US)
• Paige (US)

Market Dynamics:
Drivers-
The demand for digital pathology systems in the cancer research sector is being driven by the success of these systems in research. This has also attracted government investors to invest in digital pathology systems for clinical diagnostics applications. The adoption of {{keyword}} is expected to increase in the future due to technological advancements such as computerization, robotic light microscopy, and multiple fiber optic communications. Additionally, the device may benefit from the high demand for great-throughput technologies for drug discovery. The adoption of pathological digitization may also increase demand for the services. These factors could fuel the market expansion for digital pathology.

Challenges:
The deployment of these devices is expected to be constrained by their high cost and the difficulty of finding qualified individuals to operate digital pathology devices. Additionally, strict regulatory concerns for primary diagnosis and a lack of uniform norms for digital pathology are anticipated to be inhibitors to market expansion over the forecast period.

Regional Trends:
During the forecast period, the digital pathology products market in North America is mature. The primary drivers of the market's growth are the increasing prevalence of cancer, the expansion of digital pathology in pharmaceutical research and online as a component, and the ever-increasing adoption of digital pathology to enhance lab efficiency. Additionally, Europe possessed a significant portion of the digital pathology market. As customers' preferences for digital instruments increased, the necessity for digital pathology increased.Furthermore, the market is expected to expand as a result of the increased utilization of products that incorporate advanced technology.

Recent Developments:
• Thermo Fisher Scientific, Inc. introduced the Ion Torrent Genexus Dx Integrated Sequencer in March 2022. This automated next-generation sequencing (NGS) platform is designed for use in clinical laboratories and to conduct diagnostic and clinical research. It has been certified with the CE-IVD mark.

• The Catalan Health Institute and 3DHISTECH Ltd. executed a contract in April 2022. The objective of this strategy was to employ digital pathology tools throughout an eight-hospital network.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1629

Segmentation of Digital Pathology Market-

By Product
• Scanners
• Brightfield
• Other Scanners
• Software
• Integrated Software
• Standalone Software
• Information Management Software
• Image Analysis Software
• Storage Systems

By Application
• Drug Discovery
• Disease Diagnosis
• Training & Education
By Type
• Human Pathology
• Veterinary Pathology
By End User
• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Details insights on this market: https://www.insightaceanalytic.com/report/digital-pathology-market/1629

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email: info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.